Connection

ANDREW LEE to Treatment Outcome

This is a "connection" page, showing publications ANDREW LEE has written about Treatment Outcome.
Connection Strength

0.241
  1. Ocular Myasthenia Gravis 32 years From Remission to Relapse. J Neuroophthalmol. 2023 06 01; 43(2):e45-e46.
    View in: PubMed
    Score: 0.063
  2. The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis. J Neuroophthalmol. 2021 Sep 01; 41(3):342-350.
    View in: PubMed
    Score: 0.062
  3. Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial. Toxins (Basel). 2021 01 21; 13(2).
    View in: PubMed
    Score: 0.060
  4. Should steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy? J Neuroophthalmol. 2010 Jun; 30(2):193-8.
    View in: PubMed
    Score: 0.029
  5. Point Counter-Point: Thymectomy in Ocular Myasthenia Gravis. J Neuroophthalmol. 2022 12 01; 42(4):541-546.
    View in: PubMed
    Score: 0.017
  6. Isolated, Transient, Pneumocephalus-Induced Oculomotor Neuropathy After Microvascular Decompression of the Trigeminal Nerve. World Neurosurg. 2016 Apr; 88:690.e17-690.e22.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.